| Todd Jude Rodrigue, PT | |
|
2626 North Drive, Abbeville, LA 70510 | |
| (337) 893-4500 | |
| (337) 893-2979 |
| Full Name | Todd Jude Rodrigue |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 34 Years |
| Location | 2626 North Drive, Abbeville, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861453755 | NPI | - | NPPES |
| 1566292 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 01223 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Laborde Therapy Center Llc | 2668469545 | 14 |
| Physical Therapy Clinic Of Lafayette, Inc. | 9931283223 | 9 |
| Vermilion Physical Therapy Inc | 9739121054 | 5 |
News Archive
Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.
› Verified 9 days ago
| Provider Name | Laborde Therapy Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1811997448 PECOS PAC ID: 2668469545 Enrollment ID: O20040430000870 |
News Archive
Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.
› Verified 9 days ago
| Provider Name | Vermilion Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043267875 PECOS PAC ID: 9739121054 Enrollment ID: O20050527000195 |
News Archive
Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.
› Verified 9 days ago
| Provider Name | Abbeville General Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285779363 PECOS PAC ID: 8325933872 Enrollment ID: O20060217000566 |
News Archive
Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.
› Verified 9 days ago
| Provider Name | Physical Therapy Clinic Of Lafayette, Inc. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1538129408 PECOS PAC ID: 9931283223 Enrollment ID: O20080226000160 |
News Archive
Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd Jude Rodrigue, PT 2626 North Drive, Abbeville, LA 70510 Ph: (337) 893-4500 | Todd Jude Rodrigue, PT 2626 North Drive, Abbeville, LA 70510 Ph: (337) 893-4500 |
News Archive
Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.
› Verified 9 days ago
Whitney L Atchetee Ltd Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 317 Odea St, Abbeville, LA 70510 Phone: 337-893-3258 Fax: 337-898-0495 | |
Vermilion Physical Therapy Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 2626 North Drive, Abbeville, LA 70510 Phone: 337-893-4500 Fax: 337-893-2979 | |
Kacie Pertuit, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3013 Veterans Memorial Dr Ste 104, Abbeville, LA 70510 Phone: 337-993-2766 | |
Sensory Pathways, Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9029 Redwood Rd, Abbeville, LA 70510 Phone: 337-892-0725 Fax: 337-893-6607 | |
Ross Thomas Landry, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 317 Odea St, Abbeville, LA 70510 Phone: 337-893-3258 Fax: 337-898-0495 | |
Emma Granger, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 19103 Theall Rd, Abbeville, LA 70510 Phone: 337-893-1602 | |
Prof. Alexandra Marceaux Hebert, P. T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 317 Odea St, Abbeville, LA 70510 Phone: 337-893-3258 Fax: 337-898-0495 |